The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
CJC-1295 is discussed for its ability to support growth hormone release by acting on growth hormone-releasing hormone pathways
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Cell 188 , 71557174.e25 (2025)
The pharmacological profile of GHK-Cu observed in preclinical models covers a broad spectrum of activity: Stimulation of extracellular matrix synthesis influence on the production of collagen, elastin and glycosaminoglycans in dermal fibroblasts Pro-regenerative and pro-angiogenic effects in in vivo and in vitro wound healing models Modulation of gene expression in transcriptomic studies, the impact on hundreds of tissue repair and antioxidant defense genes Transport of copper ions GHK as a physiological carrier of Cu, a cofactor of matrix enzymes Antioxidant and anti-inflammatory activity reduction of oxidative stress markers in cell models GHK-Cu is a model ligand for testing in the group of plasma peptides connective tissue remodeling and copper biology combines a signaling function with trace element transport, making it a tool for studying the interface between copper metabolism and extracellular matrix repair

Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome